CITADEL ADVISORS LLC 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:22 am Sale |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
CITADEL ADVISORS LLC | 40,760 4.500% |
-775 (-1.87%) |
Filing |
| 2021-07-06 4:03 pm Purchase |
2021-06-25 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
CITADEL ADVISORS LLC | 41,536 5.200% |
41,536 (New Position) |
Filing |